Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avexxin A/S
DescriptionSmall molecule targeting group IValpha phospholipase A2 (GIValphaPLA2) enzyme
Molecular Target Phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) (cPLA2-alpha)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today